Heart rate and QT variability in children with anxiety disorders: A preliminary report
โ Scribed by Vikram K. Yeragani; K.A. Radhakrishna Rao; Robert Pohl; V.C. Jampala; Richard Balon
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 86 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.1019
No coin nor oath required. For personal study only.
โฆ Synopsis
This study compared beat-to-beat heart rate and QT variability in children with anxiety disorders (n=7) and normal controls (n=15) by using an automated algorithm to compute QT intervals. An increase in QT variability appears to be associated with a higher risk for sudden cardiac death. A decrease in heart rate variability is also linked to significant cardiovascular events. Supine detrended QT variability, QT variability corrected for mean QT interval, and QTvi (a log ratio of QT variance normalized for mean QT over heart rate variability normalized for mean heart rate) were significantly higher in children with anxiety compared to controls (P<0.05). The largest Lyapunov Exponent (LLE) of heart rate time series was significantly lower (P<0.05) in children with anxiety compared to controls. These findings suggest a relative increase in sympathetic activity and a relative decrease in cardiac vagal activity in children with anxiety disorders, and are discussed in the context of the effects of tricyclics on cardiac autonomic function in children, and the rare occurrence of sudden death during tricyclic antidepressant treatment. Depression and
Anxiety 13:72-77, 2001.
๐ SIMILAR VOLUMES
## Abstract ## Objectives: We tested whether dynamic interaction between limbic regions supports a control systems model of excitatory and inhibitory components of a negative feedback loop, and whether dysregulation of those dynamics might correlate with trait differences in anxiety and their card
## Abstract This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. __Cochrane Database of Systematic Reviews__ 2009, Issue 3. Art. No.: CD005170. DOI